Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets

About Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets

DAPAVILDA MET 10/100/500 is a combination anti-diabetic medicine containing Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 500 mg Tablets. This advanced formulation is widely prescribed for the effective management of Type 2 Diabetes Mellitus in adults. The medicine helps control high blood sugar levels and supports overall metabolic health when combined with a balanced diet and regular exercise.

The triple combination works through different mechanisms to improve glucose control. Dapagliflozin helps remove excess sugar through urine, Vildagliptin increases insulin release after meals, and Metformin SR reduces glucose production in the liver while improving insulin sensitivity. Together, these ingredients provide comprehensive blood sugar management and help reduce the risk of diabetes-related complications.

DAPAVILDA MET 10/100/500 is designed for patients who require stronger glycemic control and long-term diabetes management. The sustained-release formulation of Metformin ensures gradual drug release, improving patient comfort and compliance.

Uses of DAPAVILDA MET 10/100/500

Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets are commonly used for:

• Management of Type 2 Diabetes Mellitus
• Controlling elevated blood sugar levels
• Improving insulin sensitivity
• Supporting pancreatic insulin secretion
• Reducing post-meal glucose spikes
• Lowering the risk of diabetes-related complications
• Helping maintain long-term glycemic control
• Supporting weight and metabolic management in diabetic patients

This medicine is generally prescribed when diet, exercise, and single-drug therapy are not sufficient to maintain optimal blood sugar levels.

Benefits of DAPAVILDA MET 10/100/500

Effective Triple Action Formula

The combination of Dapagliflozin, Vildagliptin SR, and Metformin SR provides comprehensive diabetes management through multiple pathways.

Better Blood Sugar Control

The medicine helps maintain stable blood glucose levels throughout the day and reduces sudden sugar fluctuations after meals.

Supports Weight Management

Dapagliflozin may assist in reducing excess glucose calories through urine, which can support healthy weight management in some patients.

Improved Insulin Sensitivity

Metformin SR improves the bodys response to insulin and decreases excess glucose production in the liver.

Convenient Sustained Release Therapy

The sustained-release formulation helps provide prolonged action and may reduce gastrointestinal discomfort associated with regular Metformin.

Reduces Risk of Complications

Maintaining proper blood sugar control can help reduce the long-term risk of kidney damage, nerve problems, cardiovascular disease, and vision-related complications associated with diabetes.

Dosage of DAPAVILDA MET 10/100/500

DAPAVILDA MET 10/100/500 should be taken exactly as prescribed by a healthcare professional. The dosage depends on the patients medical condition, blood sugar levels, and response to treatment.

• Usually taken once daily with meals
• Swallow the tablet whole with water
• Do not crush, chew, or break the sustained-release tablet
• Maintain a healthy diet and regular exercise routine while using this medicine
• Monitor blood glucose levels regularly as advised by the doctor

Missing doses or irregular usage may affect diabetes control. Patients should follow the prescribed schedule consistently for maximum benefits.

Side Effects of DAPAVILDA MET 10/100/500

Like all medicines, Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets may cause some side effects. Most side effects are mild and temporary.

Common side effects include:

• Frequent urination
• Increased thirst
• Nausea
• Stomach discomfort
• Diarrhea
• Headache
• Weakness or fatigue
• Urinary tract infection
• Genital fungal infections
• Low blood sugar when used with other anti-diabetic medicines

Seek immediate medical attention if severe allergic reactions, breathing difficulties, severe dehydration, or unusual symptoms occur.

Precautions and Warnings

Before taking DAPAVILDA MET 10/100/500, patients should inform their doctor about their complete medical history.

Kidney and Liver Conditions

Patients with kidney or liver disease should use this medicine cautiously, as dose adjustments may be required.

Pregnancy and Breastfeeding

Pregnant or breastfeeding women should use this medicine only under medical supervision.

Alcohol Consumption

Excessive alcohol intake should be avoided as it may increase the risk of side effects and affect blood sugar control.

Hydration

Dapagliflozin may increase urination, so maintaining proper hydration is important to avoid dehydration.

Regular Monitoring

Routine monitoring of blood glucose, kidney function, and overall diabetic health is recommended during treatment.

Not for Type 1 Diabetes

This medicine is not intended for the treatment of Type 1 Diabetes Mellitus or diabetic ketoacidosis.

Conclusion

DAPAVILDA MET 10/100/500 is an advanced anti-diabetic combination containing Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets that helps provide effective and long-term blood sugar control in patients with Type 2 Diabetes Mellitus. Its triple-action formula supports better glucose regulation, improved insulin sensitivity, and reduced risk of diabetic complications.

With proper medical guidance, healthy lifestyle habits, and regular monitoring, DAPAVILDA MET 10/100/500 can play an important role in maintaining overall diabetic wellness and improving quality of life for patients managing chronic diabetes.